Reckitt Benckiser Group plc (3RB:XETRA) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Reckitt Benckiser Group plc stock forecast from 0 analysts, the average analyst target price for Reckitt Benckiser Group plc is not available over the next 12 months. Reckitt Benckiser Group plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Reckitt Benckiser Group plc is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Reckitt Benckiser Group plc’s stock price was EUR 48.70. Reckitt Benckiser Group plc’s stock price has changed by -3.41% over the past week, -6.56% over the past month and -33.01% over the last year.
No recent analyst target price found for Reckitt Benckiser Group plc
No recent average analyst rating found for Reckitt Benckiser Group plc
Company Overview Reckitt Benckiser Group plc
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands. The company also offers home fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfecting sprays wipes, laundry sanitisers, and others; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands. In addition, it provides nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom. Address: Turner House, Slough, United Kingdom, SL1 3UH Read Less
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congesti...Read More
Frequently Asked Questions About Reckitt Benckiser Group plc (3RB:XETRA) Stock
Stock Target Advisor's fundamental analysis for Reckitt Benckiser Group plc's stock is Neutral.
3RB:XETRA stock's dividend yield is 4.62%.
Our analysis grades 3RB:XETRA stock's dividend yield at B+. This means that 3RB:XETRA stock's dividend yield is above 88% of the stocks in the Household & Personal Products sector in the XETRA exchange.
Based on this 3RB:XETRA may be a good dividend stock for its sector.
Unfortunately we do not have enough data on 3RB:XETRA's stock to indicate what its average analyst target is.
3RB:XETRA stock's Price/Earning ratio is 18.32.
Our analysis grades 3RB:XETRA stock's Price / Earning ratio at B+. This means that 3RB:XETRA stock's Price/Earning ratio is above 11% of the stocks in the Household & Personal Products sector in the XETRA exchange.
Based on this 3RB:XETRA may be undervalued for its sector.
The last closing price of 3RB:XETRA's stock was EUR 48.70.
The most recent market capitalization for 3RB:XETRA is EUR 34.44B.
Unfortunately we do not have enough analyst data on 3RB:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Reckitt Benckiser Group plc's stock.
As per our most recent records Reckitt Benckiser Group plc has 40,000 Employees.
Reckitt Benckiser Group plc's registered address is Turner House, Slough, United Kingdom, SL1 3UH.
You can get more information about it from Reckitt Benckiser Group plc's website at https://www.reckitt.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 3RB:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
